Financials
- Market Capitalization 653.87 M
- Employee 102
- Founded 2010
- CEO Brian Stuglik
- Website www.verastem.com
- Headquarter Massachusetts, United States
- FIGI BBG001J2LSK5
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-1.7
ratio cours/chiffre d'affaires
3.84
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2746 | SGMT Sagimet Biosciences Inc. - Series A Common Stock | 10.55 USD | -1.86% | +4.25% | +56.53% | +42.38% | 655.77 M USD | ||
| 2748 | PRME Prime Medicine, Inc. - Common Stock | 3.61 USD | -0.82% | +6.80% | +24.91% | +13.88% | 654.77 M USD | ||
| 2756 | CRMD CorMedix Inc. - Common Stock | 8.30 USD | -0.12% | +0.73% | +9.21% | -26.55% | 646.94 M USD | ||
| 2764 | RGNX REGENXBIO Inc. - Common Stock | 9.66 USD | +3.09% | +16.53% | 0.00% | -28.07% | 637.69 M USD |